Table 4. Cox regression multivariate models for ADCs and NADCs.
| Variable | Categories | ADCs | NADCs | ||
| HR (95%CI) | P-value | HR (95%CI) | P-value | ||
| Gender | Male vs Female | 1.4 (0.86–2.20) | 0.179 | 1.2 (0.78–1.78) | 0.443 |
| Age, years | |||||
| 18–34Rif | 1Rif | 1Rif | - | ||
| 35–49 | 1.3 (0.77–2.15) | 0.338 | 1.2 (0.62–2.39) | 0.576 | |
| 50-max | 1.7 (0.94–3.19) | 0.077 | 1.8 (0.91–3.68) | 0.092 | |
| Years of Diagnosis | |||||
| 1998–2002 | 1Rif | 1Rif | - | ||
| 2003–2007 | 1.15 (0.77–1.71) | 0.487 | 1.2 (0.81–1.82) | 0.354 | |
| 2008–2012 | 0.88 (0.51–1.51) | 0.641 | 0.8 (0.49–1.32) | 0.398 | |
| cART Therapy | Yes vs No | 0.5 (0.34–0.82) | 0.004 | 0.8 (0.52–1.33) | 0.452 |
| CD4+ count at diagnosis, cell/mm3 | 0–199 vs 200-max | 2.4 (1.59–3.49) | <0.001 | 1.5 (1.05–2.08) | 0.025 |
| IVDU | Yes vs No | 1.9 (1.30–2.77) | 0.001 | 1.6 (1.13–2.34) | 0.008 |
| HIV RNA at diagnosis | Positive vs. undetectable | 1.6 (0.99–2.53) | 0.060 | 1.2 (0.85–1.74) | 0.281 |
| Previous AIDS event | Yes vs No | 1.0 (0.70–1.46) | 0.944 | 1.2 (0.91–1.74) | 0.168 |
Note: ADCs: AIDS-defining cancers, NADCs: Non-AIDS-defining cancers, IVDU: injection drug users, cART: combined antiretroviral therapy; HR: Hazard ratio; CI: confidence interval.